Presymptom Health Secures £200k for AI-Driven Infection Detection
Deal News | Feb 28, 2025 | Business Cloud
Presymptom Health, a Leeds-based startup, has received £200,000 in grant funding to advance its AI-powered infection detection technology. This funding will enable the company to make its rapid tests compatible with a variety of PCR machines, thereby streamlining diagnostics in secondary care settings. Established as a spinout from the UK Ministry of Defence's Defence Science & Technologies Laboratory in 2019, Presymptom Health utilizes technology initially researched for biological threat infections. The company's InfectiClear technology can identify infections up to three days earlier than current methods by analyzing RNA-based responses rather than searching for pathogens. This approach is critical in saving lives and combating antibiotic resistance. The newly secured funding, which includes contributions from the National Institute for Health and Care Research and the Small Business Research Initiative Healthcare Grant, will also support compatibility with platforms from QuantuMDx and Bio Molecular Systems. Further plans for a Series A funding round aim to facilitate Presymptom Health's expansion into the US market.
Sectors
- MedTech
- Healthcare
- Artificial Intelligence
Geography
- United Kingdom – Presymptom Health is a Leeds-based startup, and its technology is being developed for use within the NHS, a key healthcare system in the UK.
- United States – The company plans to expand into the US market, indicating a geographical focus on North America in future business strategies.
Industry
- MedTech – The article discusses Presymptom Health's development and application of infection detection technology, which falls within the MedTech industry, focusing on medical diagnostics and healthcare innovations.
- Healthcare – Involves improving patient diagnoses and healthcare system efficiency, which is central to Presymptom Health's technology targeting early infection detection and antibiotic resistance.
- Artificial Intelligence – The article highlights AI-driven infection detection methods, underlining the use of artificial intelligence in enhancing medical diagnostics.
Financials
- £200,000 – Total grant funding secured by Presymptom Health to advance its infection detection technology.
- £100,000 – Part of the funding from the National Institute for Health and Care Research.
- £100,000 – Part of the funding from the Small Business Research Initiative Healthcare Grant.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Presymptom Health | Target | Company | A Leeds-based startup focusing on AI-driven infection detection technology. |
| Ploughshare | Other | Company | The company responsible for commercializing innovations from the UK Ministry of Defence. |
| UK Ministry of Defence (MoD) | Selling Company | Government | The governmental department from which Presymptom Health was spun out. |
| National Institute for Health and Care Research (NIHR) | Other | Company | Provided part of the grant funding for Presymptom Health. |
| Small Business Research Initiative (SBRI) | Other | Company | A funding program that provided grant support to Presymptom Health. |
| Bio Molecular Systems (BMS) | Other | Company | Manufacturer of PCR platforms that Presymptom’s technology aims to be compatible with. |
| Health Innovation Oxford and Thames Valley (HIOTV) | Other | Company | Collaborating with Presymptom on a feasibility project to understand NHS adoption of the tech. |
| QuantuMDx | Other | Company | Manufacturer of a PCR platform for which Presymptom’s tech is being made compatible. |
| ThermoFisher Scientific | Other | Company | Maker of the Quantstudio 5 PCR platform to be used with Presymptom’s technology. |